These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9485553)

  • 1. Development, validation, and interlaboratory comparison of an HMG-CoA reductase inhibition assay for quantitation of atorvastatin in plasma matrices.
    Shum YY; Huang N; Walter G; Black A; Sekerke C; Chang T; Whitfield LR
    Ther Drug Monit; 1998 Feb; 20(1):41-9. PubMed ID: 9485553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated enzyme inhibition assay method for the determination of atorvastatin-derived HMG-CoA reductase inhibitors in human plasma using radioactivity detection.
    Valesky RJ; Liu L; Musson DG; Zhao JJ
    J Pharmacol Toxicol Methods; 2008; 57(1):61-9. PubMed ID: 17651990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma.
    Bullen WW; Miller RA; Hayes RN
    J Am Soc Mass Spectrom; 1999 Jan; 10(1):55-66. PubMed ID: 9888185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
    Lilja JJ; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Aug; 66(2):118-27. PubMed ID: 10460065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple and rapid HPLC method for the determination of atorvastatin in human plasma with UV detection and its application to pharmacokinetic studies.
    Zarghi A; Shafaati A; Foroutan SM; Khoddam A
    Arzneimittelforschung; 2005; 55(8):451-4. PubMed ID: 16149712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cimetidine does not alter atorvastatin pharmacokinetics or LDL-cholesterol reduction.
    Stern RH; Gibson DM; Whitfield LR
    Eur J Clin Pharmacol; 1998 Feb; 53(6):475-8. PubMed ID: 9551707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and excretion studies in mouse after single and multiple oral doses of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.
    Black AE; Sinz MW; Hayes RN; Woolf TF
    Drug Metab Dispos; 1998 Aug; 26(8):755-63. PubMed ID: 9698289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
    Krause BR; Newton RS
    Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin coadministration increases plasma atorvastatin concentrations.
    Siedlik PH; Olson SC; Yang BB; Stern RH
    J Clin Pharmacol; 1999 May; 39(5):501-4. PubMed ID: 10234598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantification of atorvastatin and active metabolites in human plasma by liquid chromatography-tandem mass spectrometry using rosuvastatin as internal standard.
    Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Maurya S; Boosi R; Anjaneyulu Y
    Biomed Chromatogr; 2006 Sep; 20(9):924-36. PubMed ID: 16470513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin is not cataractogenic in beagle dogs.
    Robertson DG; Urda ER; Rothwell CE; Walsh KM
    Curr Eye Res; 1997 Dec; 16(12):1229-35. PubMed ID: 9426956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high-performance liquid chromatography with electrospray tandem mass spectrometry.
    Jemal M; Ouyang Z; Chen BC; Teitz D
    Rapid Commun Mass Spectrom; 1999; 13(11):1003-15. PubMed ID: 10368976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
    Yee HS; Fong NT
    Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.
    Conde K; Roy S; Freake HC; Newton RS; Fernandez ML
    Lipids; 1999 Dec; 34(12):1327-32. PubMed ID: 10652993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor.
    Stern RH; Yang BB; Hounslow NJ; MacMahon M; Abel RB; Olson SC
    J Clin Pharmacol; 2000 Jun; 40(6):616-23. PubMed ID: 10868312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes.
    Dostalek M; Sam WJ; Paryani KR; Macwan JS; Gohh RY; Akhlaghi F
    Clin Pharmacokinet; 2012 Sep; 51(9):591-606. PubMed ID: 22775412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers.
    Amsden GW; Kuye O; Wei GC
    J Clin Pharmacol; 2002 Apr; 42(4):444-9. PubMed ID: 11936570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin.
    Bergstrom JD; Bostedor RG; Rew DJ; Geissler WM; Wright SD; Chao YS
    Biochim Biophys Acta; 1998 Jan; 1389(3):213-21. PubMed ID: 9512650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of simvastatin-derived HMG-CoA reductase inhibitors in biomatrices using an automated enzyme inhibition assay with radioactivity detection.
    Liu L; Zhang R; Zhao JJ; Rogers JD; Hsieh JY; Fang W; Matuszewski BK; Dobrinska MR
    J Pharm Biomed Anal; 2003 Apr; 32(1):107-23. PubMed ID: 12852453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.